Key result
In paediatric patients with idiopathic or hereditary pulmonary arterial hypertension, every one-unit decrease in pressure-derived ventricular-vascular coupling (Ees/Ea_Takeuchi) increased the hazard of severe adverse events by 4.34-fold.
Why the study?
Ventricular-vascular coupling may be useful in paediatric pulmonary arterial hypertension, but the prognostic capacity of the ratio derived using right ventricular pressure alone remained to be assessed.
Does the ventricular-vascular coupling ratio (Ees/Ea) derived from RV pressure alone predict adverse clinical outcomes in pediatric patients with pulmonary arterial hypertension?
Cohort (n=130)
No
Does the ventricular-vascular coupling ratio (Ees/Ea) derived from RV pressure alone predict adverse clinical outcomes in pediatric patients with pulmonary arterial hypertension?
Hazard Ratio: 4.34 (95% CI 3.6–10)
p-value: p=0.001
Ventricular-vascular coupling derived from right ventricular pressure alone is a strong independent predictor of severe adverse outcomes in pediatric patients with idiopathic or hereditary pulmonary arterial hypertension.
Aims Ventricular–vascular coupling, the ratio between the right ventricle’s contractile state (Ees) and its afterload (Ea), may be a useful metric in the management of paediatric pulmonary arterial hypertension (PAH). In this study we assess the prognostic capacity of the ventricular–vascular coupling ratio (Ees/Ea) derived using right ventricular (RV) pressure alone in children with PAH. Methods One hundred and thirty paediatric patients who were diagnosed with PAH via right heart catheterisation were retrospectively reviewed over a 10-year period. Maximum RV isovolumic pressure and end-systolic pressure were estimated using two single-beat methods from Takeuchi et al (Ees/Ea_(Takeuchi)) and from Kind et al (Ees/Ea_(Kind)) and used with an estimate of end-systolic pressure to compute ventricular–vascular coupling from pressure alone. Patients were identified as either idiopathic/hereditary PAH or associated PAH (IPAH/HPAH and APAH, respectively). Haemodynamic data, clinical functional class and clinical worsening outcomes—separated into soft (mild) and hard (severe) event categories—were assessed. Adverse soft events included functional class worsening, syncopal event, hospitalisation due to a proportional hazard-related event and haemoptysis. Hard events included death, transplantation, initiation of prostanoid therapy and hospitalisation for atrial septostomy and Pott’s shunt. Cox proportional hazard modelling was used to assess whether Ees/Ea was predictive of time-to-event. Results In patients with IPAH/HPAH, Ees/Ea_(Kind) and Ees/Ea_(Takeuchi) were both independently associated with time to hard event (p=0.003 and p=0.001, respectively) and when adjusted for indexed pulmonary vascular resistance (p=0.032 and p=0.013, respectively). Neither Ees/Ea_(Kind) nor Ees/Ea_(Takeuchi) were associated with time to soft event. In patients with APAH, neither Ees/Ea_(Kind) nor Ees/Ea_(Takeuchi) were associated with time to hard event or soft event. Conclusions Ees/Ea derived from pressure alone is a strong independent predictor of adverse outcome and could be a potential powerful prognostic tool for paediatric PAH.
No takes yet. Share an insight, caveat, or question.
Dufva et al. (2021) conducted a cohort in Paediatric pulmonary arterial hypertension (PAH) (n=130). Ventricular-vascular coupling ratio (Ees/Ea) derived from right ventricular pressure vs. Higher vs lower Ees/Ea ratio was evaluated on Time to hard event (death, transplantation, initiation of prostanoid therapy, or hospitalisation for atrial septostomy/Pott's shunt) in IPAH/HPAH patients (HR 4.34, 95% CI 3.6-10.0, p=0.001). In paediatric patients with idiopathic or hereditary pulmonary arterial hypertension, every one-unit decrease in pressure-derived ventricular-vascular coupling (Ees/Ea_Takeuchi) increased the hazard of severe adverse events by 4.34-fold.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: